2013
DOI: 10.1002/pbc.24503
|View full text |Cite
|
Sign up to set email alerts
|

Hemoglobin shady grove: A novel fetal methemoglobin variant

Abstract: Recommendations by the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children aim to increase congenital heart disease screening by pulse oximetry in the nursery. Here, we describe a novel fetal methemoglobin variant discovered in a newborn found to have oxygen saturations significantly below normal upon pulse oximetry screening for congenital heart disease. As universal newborn screening with pulse oximetry is implemented, hereditary variant h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…3.6.9.8. Specific susceptible population groups Increased methaemoglobinaemia is reported to occur in patients with a genetic defect of cytochrome b5 reductase types 1 and 2 (Percy and Lappin, 2008;Lorenzo et al, 2011) and in patients with hereditary methaemoglobinaemia, an autosomal dominant disorder caused by mutations in the globin chains, called haemoglobin M (Hb M) disease with at least 10 known mutations, occurring in either the a, b, or g globin genes (Marks et al, 2013). Neonates and infants have a reduced level of cytochrome b5 reductase (about 50-60% of the adult level) (Ross, 1963;Bartos and Desforges, 1966).…”
Section: Assessment Of Mode Of Actionmentioning
confidence: 99%
“…3.6.9.8. Specific susceptible population groups Increased methaemoglobinaemia is reported to occur in patients with a genetic defect of cytochrome b5 reductase types 1 and 2 (Percy and Lappin, 2008;Lorenzo et al, 2011) and in patients with hereditary methaemoglobinaemia, an autosomal dominant disorder caused by mutations in the globin chains, called haemoglobin M (Hb M) disease with at least 10 known mutations, occurring in either the a, b, or g globin genes (Marks et al, 2013). Neonates and infants have a reduced level of cytochrome b5 reductase (about 50-60% of the adult level) (Ross, 1963;Bartos and Desforges, 1966).…”
Section: Assessment Of Mode Of Actionmentioning
confidence: 99%